Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
Information source: Rikshospitalet HF
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Epilepsy; Mental Retardation
Intervention: Ketogenic diet (Dietary Supplement); Antiepileptic drug (AED) (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Rikshospitalet HF Official(s) and/or principal investigator(s):
Bjorn Bjurulf, Cand med, Principal Investigator, Affiliation: SSE, Nevrological dep., Rikshospitalet University Hospital
Overall contact:
Bjorn Bjurulf, cand. med, Phone: 47 67501000, Email: bjorn.bjurulf@epilepsy.no
Summary
This is an open randomized controlled study in children with mental retardation and
refractory epilepsy in which treatment with ketogenic diet (KD) is compared with treatment
with the antiepileptic drug (AED), not tried by the patient before, which we consider to be
the most appropriate AED for the patient.
Clinical Details
Official title: Comparing Ketogenic Diet With the Most Appropriate Antiepileptic Drug- a Randomized Study of Children With Mental Retardation and Drug Resistant Epilepsy
Study design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Primary outcome: Comparing amount of patients with 100%, >90% and >50% reduction
in number of seizures between the two groups
of seizures
Secondary outcome: Comparing the parents´evaluation of change in quality of life and
cognitive function between the two groups. The parents will
answer a questionary.Comparing side effects between the two groups Comparing change in slow activity and epileptic activity by template matching
on 24 hour EEG Investigating side effects and change in number of seizures, change in EEG, quality of life and cognitive function after 13 months of treatment with the ketogenic diet Is the effect of the ketogenic diet as good in children with severe mental retardation as in children with less severe learning disabilities?
Detailed description:
There are two trials in the study:
- To compare the effect of the ketogenic diet with the effect of the most appropriate
AED after 4 months
- To evaluate the effect of the ketogenic diet after 4 and 13 months on the children who
have been randomized to this treatment, the seizure frequency is compared with the
frequency before start of treatment
Eligibility
Minimum age: 2 Years.
Maximum age: 15 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- The patient is mentally retarded
- The patient has tried at least 3 different AED: s including one combination with two
or more different AED: s.
- The parents are willing to include their child in the study after written and verbal
information.
- Patients with all types of epilepsy can be included.
- The patient has at least 6 seizures/month.
- The patient is submitted to our epilepsy center.
- The seizures are possible to count
- The patient has either generalized epilepsy, multifocal epilepsy or an epilepsy where
it is undetermined whether it is localized or generalized such as Dravet syndrome
classified as G40. 3-G40. 9 in ICD X.
Exclusion Criteria:
- The family is expected to have compliance problems with treatment and/or seizure
registration.
- The hospital which have submitted the patient is not willing to accept the inpatient
stays and the procedures that are necessary for the project.
- The patient`s seizures are under acceptable control.
- The patient has got a vagus nerve stimulator implanted within the last 18 months, has
started a new antiepileptic drug within the last 2 months or has changed his
antiepileptic drugs the last month.
- The patient has a medical condition, for example a metabolic disease, where ketogenic
diet is contraindicated.
- The patient has a localized epilepsy classified as G40. 0-G40. 2 in ICD X.
- The patient`s nutritional status is not good enough or intake of fluid is to small to
permit treatment with ketogenic diet.
- The patient has within the last 2 months been using medications or herbal medications
that has a considerable effect on glucose metabolism, such as oral glucocorticoids.
- The patient has within the last 2 months been using medications or herbal medications
that has a considerable effect on metabolism of AED: s.
- The patient uses herbal medicine which can interact with AED or Ketogenic diet.
Locations and Contacts
Bjorn Bjurulf, cand. med, Phone: 47 67501000, Email: bjorn.bjurulf@epilepsy.no
SSE, Nevrological dep. , Rikshospitalet University hospital, Oslo, Norway; Recruiting
Bjorn Bjurulf, Cand med, Phone: 47- 67501000, Email: bjorn.bjurulf@ulleval.no
Ann-Sofie Eriksson, Dr med, Phone: 47-67501000, Email: ann-sofie.eriksson@epilepsy.no
Additional Information
Related publications: Pulsifer MB, Gordon JM, Brandt J, Vining EP, Freeman JM. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev Med Child Neurol. 2001 May;43(5):301-6. Kossoff EH, McGrogan JR. Worldwide use of the ketogenic diet. Epilepsia. 2005 Feb;46(2):280-9. Levy R, Cooper P. Ketogenic diet for epilepsy. Cochrane Database Syst Rev. 2003;(3):CD001903. Review. Kang HC, Kim YJ, Kim DW, Kim HD. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia. 2005 Feb;46(2):272-9. Kossoff EH, Pyzik PL, McGrogan JR, Vining EP, Freeman JM. Efficacy of the ketogenic diet for infantile spasms. Pediatrics. 2002 May;109(5):780-3. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000 Apr;105(4):E46. Review.
Starting date: November 2007
Ending date: December 2013
Last updated: January 28, 2008
|
